ERBB2 and breast cancer: In fact, statistical analysis, using the ELDA software [47], revealed a significant increase in the stem cell frequency of the brain-tropic breast cancer cells (p < 0.0001), although no significant differences were observed between 231.Br and 231.Br.HER2.